Devicor Medical Products Buys Assets from Neoprobe

Devicor Medical Products, a company backed by GTCR, has completed its acquisition of certain products and assets from Neoprobe Corp. The deal included $30 million in cash payments at closing plus up to $20 million in potential milestone-based royalties.

DealsNorth AmericaUSBriefs